RecruitingNot Applicable

Doxapram Administration on Diaphragmatic Excursion in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease Undergoing Spontaneous Breathing Trial

Egypt35 participantsStarted 2025-06-22

Plain-language summary

Researchers aim to evaluate the impact of doxapram administration on diaphragmatic excursion in chronic obstructive pulmonary disease (COPD) patients undergoing spontaneous breathing trial

Who can participate

Age range20 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with moderate to severe chronic obstructive pulmonary disease undergoing spontaneous breathing trial Exclusion Criteria: * Refusal Allergy to doxapram neuromuscular disorders inability to evaluate the diaphragm

What they're measuring

• Diaphragmatic excursion in mm

Timeframe: before and 10 minutes after doxappram

Trial details

NCT IDNCT07022704

SponsorCairo University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-10-30

Contact for this trial

Mina Helmy, MD

+201007174836 dr_mina20002010@yahoo.com

View on ClinicalTrials.gov More COPD trials